Twist Bioscience Corporation TWST Cash Flow Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$81.28M-6.1% | -$76.58M+1.4% | -$77.67M+8.8% | -$85.19M+55.4% | -$191.15M+3.1% | ||
| $24.68M0.0% | $24.67M-0.7% | $24.85M-2.6% | $25.51M-8.1% | $27.74M-6.4% | ||
| $64.35M-2.1% | $65.74M+2.0% | $64.46M+6.2% | $60.72M+4.0% | $58.4M+12.5% | ||
| $14.62M+31.7% | $11.11M-50.6% | $22.47M— | —— | —— | ||
| $12.65M+34.5% | $9.4M+122% | $4.23M+266% | -$2.55M+73.2% | -$9.52M-29.6% | ||
| $4.74M-11.9% | $5.38M-44.1% | $9.62M+103% | $4.74M+1,285% | $342K+118% | ||
| -$1.79M-143% | $4.12M-28.3% | $5.75M+54.7% | $3.72M-3.0% | $3.83M-17.6% | ||
| $1.38M+37.3% | $1.01M-36.6% | $1.59M+155% | $622K+35.5% | $459K+149% | ||
| -$558K+70.4% | -$1.89M+14.3% | -$2.2M+11.7% | -$2.5M— | —— | ||
| —— | —— | $0— | $0— | $0— | ||
| -$55.59M-9.0% | -$51.01M-7.1% | -$47.63M+6.9% | -$51.13M+8.9% | -$56.11M+10.3% | ||
| $39.45M+10.5% | $35.71M+27.5% | $28M+59.3% | $17.58M+87.4% | $9.38M+60.7% | ||
| $49.1M-0.4% | $49.31M-0.2% | $49.39M-0.1% | $49.45M+2.0% | $48.46M-10.5% | ||
| $46.71M-5.4% | $49.36M-1.5% | $50.14M-1.5% | $50.89M-3.8% | $52.89M+3.2% | ||
| -$44.44M-34.0% | -$33.16M-33.9% | -$24.76M-81.5% | -$13.64M-175% | -$4.96M+43.5% | ||
| —— | —— | —— | —— | —— | ||
| $7.71M+15.2% | $6.69M-28.4% | $9.34M+25.1% | $7.47M-12.7% | $8.55M-6.0% | ||
| $11.84M+8.6% | $10.89M-61.8% | $28.54M+7.3% | $26.59M-3.9% | $27.68M+5.2% | ||
| —— | $205K+43.4% | $143K+170% | $53K-57.9% | $126K— | ||
| -$88.1M-20.6% | -$73.07M-67.2% | -$43.71M-14.6% | -$38.13M-14.6% | -$33.27M+26.2% | ||
| $1.33M+53.4% | $864K+26.5% | $683K+2,870% | $23K-42.5% | $40K-87.7% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $23.46M+109% | $11.2M+201% | $3.72M+196% | $1.26M— | —— | ||
| -$558K+70.4% | -$1.89M+14.3% | -$2.2M+11.7% | -$2.5M— | —— | ||
| $46.71M-5.4% | $49.36M-1.5% | $50.14M-1.5% | $50.89M-3.8% | $52.89M+3.2% | ||
| $15K+25.0% | $12K-25.0% | $16K-27.3% | $22K-15.4% | $26K-98.3% | ||
| —— | —— | —— | —— | —— | ||
| $7.71M+15.2% | $6.69M-28.4% | $9.34M+25.1% | $7.47M-12.7% | $8.55M-6.0% | ||
| $6.62M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $0— | $0— | $0— | ||
| $1.33M+53.4% | $864K+26.5% | $683K+2,870% | $23K-42.5% | $40K-87.7% | ||
| -$95.04M-9.6% | -$86.72M-14.7% | -$75.63M-10.1% | -$68.71M-4.9% | -$65.49M+4.2% | ||
| -$95.04M-9.6% | -$86.72M-14.7% | -$75.63M-10.1% | -$68.71M-4.9% | -$65.49M+4.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Twist Bioscience Corporation generate?
- Twist Bioscience Corporation (TWST) generated -$55.6M in operating cash flow over the trailing twelve months.
- What is Twist Bioscience Corporation's free cash flow?
- After $39.5M of capital expenditures, Twist Bioscience Corporation's free cash flow was -$95.0M over the trailing twelve months, down 45.1% year over year.
- Where does Twist Bioscience Corporation's cash flow data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
